StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.1
  1. Startseite
  2. /Reaktion

Sodium Hydroxide → (-)-5-[2-(-1H-Imidazol-2-yl)pyrid-5-yl]-1-azabicyclo[3.2.1]octane

HRID 44459
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 44459
CN(C)S([N:6]1[CH:10]=[CH:9][N:8]=[CH:7]1)(=O)=O.C([Li])CCC.Br[C:18]1[CH:23]=[CH:22][C:21]([C:24]23[CH2:31][N:28]([CH2:29][CH2:30]2)[CH2:27][CH2:26][CH2:25]3)=[CH:20][N:19]=1.[OH-].[Na+]>O1CCCC1.CCCCCC.[Cl-].[Zn+2].[Cl-].C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.C(Cl)(Cl)Cl>[NH:8]1[CH:9]=[CH:10][N:6]=[C:7]1[C:18]1[CH:23]=[CH:22][C:21]([C:24]23[CH2:31][N:28]([CH2:29][CH2:30]2)[CH2:27][CH2:26][CH2:25]3)=[CH:20][N:19]=1
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

10

Edukt 4

HCID 14798Sodium HydroxideHCID 395751N,N-Dimethyl-1H-imidazole-1-sulfonamideHCID 862593785-(2-Bromopyrid-5-yl)-1-azabicyclo[3.2.1]octaneHCID 178418339Butyllithium

Produkt 1

HCID 16005059(-)-5-[2-(-1H-Imidazol-2-yl)pyrid-5-yl]-1-azabicyclo[3.2.1]octane

Reagenzien, Katalysatoren, Lösungsmittel 5

HCID 3007855
Zincchloride
Katalysator
2×
HCID 178418397HCID 178418397, VerbindungKatalysator
HCID 6212ChloroformLösungsmittel
HCID 8028TetrahydrofuranLösungsmittel3×
HCID 8058HexaneLösungsmittel

Reaktionsbedingungen

Temperatur
-78 °C

Versuchsvorschrift

1 g (5.7 mmol) of 1-(dimethylaminosulfonyl)imidazole dissolved in 9 ml of tetrahydrofuran is introduced into a 25 ml three-necked flask. The reaction medium is cooled to −78° C. and 4 ml of a 1.6M solution of n-butyllithium in hexane is added dropwise over 20 minutes. 0.73 g (5.4 mmol) of zinc chloride dissolved in 4 ml of tetrahydrofuran is then added. The mixture is stirred while allowing the temperature to return to 20° C., and 1.5 g (11.1 mmol) of zinc chloride, 0.1 g (0.09 mmol) of tetrakis(triphenylphosphine)palladium and 0.56 g (2.1 mmol) of (−)-5-(2-bromopyrid-5-yl)-1-azabicyclo[3.2.1]octane (prepared according to the method described in step 1.2 of Example 1), dissolved in 5 ml of tetrahydrofuran, are then successively added. The mixture is then refluxed for 24 hours and then cooled to room temperature. 30 ml of aqueous 30% sodium hydroxide solution and 50 ml of chloroform are added. The aqueous phase is extracted with chloroform and the combined organic phases are then washed with saturated aqueous sodium chloride solution, dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue is purified by chromatography on a column of silica gel, eluting with a mixture of chloroform, methanol and aqueous ammonia in 95/5/0.5 proportions and is used in the following step without further purification.

Aufarbeitung

  1. additionis introduced into a 25 ml three-necked flask
  2. additionis then added
  3. customto return to 20° C.
  4. additionare then successively added
  5. temperatureThe mixture is then refluxed for 24 hours
  6. temperaturecooled to room temperature
  7. extractionThe aqueous phase is extracted with chloroform
  8. washthe combined organic phases are then washed with saturated aqueous sodium chloride solution
  9. dry with materialdried over sodium sulfate
  10. filtrationfiltered
  11. concentrationconcentrated under reduced pressure
  12. customThe residue is purified by chromatography on a column of silica gel
  13. washeluting with a mixture of chloroform, methanol and aqueous ammonia in 95/5/0.5 proportions
  14. customis used in the following step without further purification

Quellen und Nachweise

ORD-Eintrag
ord-07e4670ecda44b67912d345f5548593e
Quelldatensatz
uspto-grants-2013_09
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08541440B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion